Drug Trial Radar · NCT03055013
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
819
Actual
Start
Apr 28, 2017
Primary completion
May 24, 2023
Study completion Jun 9, 2031
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Feb 16, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase III trial compares nephrectomy (surgery to remove a kidney or part of a kidney) with nivolumab to the usual approach of nephrectomy followed by standard post-operative follow-up and monitoring, in treating patients with kidney cancer that is limited to a certain part of the body (localized). Nivolumab is a drug that may help stimulate the immune system to attack any cancer cells that may remain after surgery. The addition of nivolumab to the usual surgery could prevent the cancer from returning. It is not yet known whether nivolumab and nephrectomy is more effective than nephrectomy alone in treating patients with kidney cancer.
Conditions
- Metastatic Renal Cell Carcinoma
- Sarcomatoid Renal Cell Carcinoma
- Stage II Renal Cell Cancer AJCC v7
- Stage III Renal Cell Cancer AJCC v7
- Unclassified Renal Cell Carcinoma
Interventions
NephrectomyProcedure
Undergo nephrectomy
NivolumabBiological
Given IV
Patient ObservationOther
Undergo observation
Quality-of-Life AssessmentOther
Ancillary studies
Questionnaire AdministrationOther
Ancillary studies
Primary outcomes
What the sponsor says the trial is designed to measure.
- Recurrence-free Survival (RFS) Rate at 5 YearsTime frame: Assessed at 20 weeks, 40 weeks, then every 3 months for patients <2 years from randomization, then every 6 months for 3 years
Locations
413 sites in 3 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama
Veterans Administration Medical Center - Birmingham
Birmingham, Alabama
Banner MD Anderson Cancer Center
Gilbert, Arizona
Cancer Center at Saint Joseph's
Phoenix, Arizona
Banner University Medical Center - Tucson
Tucson, Arizona
University of Arizona Cancer Center-North Campus
Tucson, Arizona
Kaiser Permanente-Anaheim
Anaheim, California
Sutter Auburn Faith Hospital
Auburn, California
AIS Cancer Center at San Joaquin Community Hospital
Bakersfield, California
Kaiser Permanente-Baldwin Park
Baldwin Park, California
Kaiser Permanente-Bellflower
Bellflower, California
Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California
Mills-Peninsula Medical Center
Burlingame, California
Community Cancer Institute
Clovis, California
City of Hope Comprehensive Cancer Center
Duarte, California
Kaiser Permanente-Fontana
Fontana, California
Kaiser Permanente South Bay
Harbor City, California
Kaiser Permanente-Irvine
Irvine, California
UC San Diego Moores Cancer Center
La Jolla, California
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California
USC / Norris Comprehensive Cancer Center
Los Angeles, California
Kaiser Permanente West Los Angeles
Los Angeles, California
Cedars-Sinai Medical Center
Los Angeles, California
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California
Fremont - Rideout Cancer Center
Marysville, California
Palo Alto Medical Foundation-Camino Division
Mountain View, California
USC Norris Oncology/Hematology-Newport Beach
Newport Beach, California
Kaiser Permanente-Oakland
Oakland, California
Kaiser Permanente-Ontario
Ontario, California
UC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California
Palo Alto Medical Foundation Health Care
Palo Alto, California
Stanford Cancer Institute Palo Alto
Palo Alto, California
VA Palo Alto Health Care System
Palo Alto, California
Kaiser Permanente - Panorama City
Panorama City, California
Eisenhower Medical Center
Rancho Mirage, California
Kaiser Permanente-Riverside
Riverside, California
Kaiser Permanente-Roseville
Roseville, California
Sutter Roseville Medical Center
Roseville, California
Kaiser Permanente Downtown Commons
Sacramento, California
Sutter Medical Center Sacramento
Sacramento, California
Showing 40 of 413 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.